Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device - Beyond the Abstract

The process of prostate enlargement originates at the capillary level when a normal physiological functioning of the capillary net gradually turns into pathological angiogenesis due to the lowering of the temperature at the capillary level. Thermobalancing therapy aims to terminate spontaneous angiogenesis via local temperature regulation over a prolonged period of time.

Therapeutic Device, termed Dr Allen’s Device for Prostate Care, is an elastic belt keepings a wax-based thermoelement in the projection of the prostate, see the photos.

therapeutic device image1

This thermoelement must be tightly applied to the coccyx area for prolonged period of time in order to accumulate body heat and act as a heat source. Thus the effect of Thermobalancing therapy occurs.

therapeutic device image2Thermobalancing therapy is much different than common heating treatments, because these do not regulate localized temperature. Treatments with imposed heat can be damaging, because the high temperatures destroy delicate cells of the already stressed organ. For example, any temperature above 104 Fahrenheit (or 40C) can result in the death of the living organism. On the other side, low temperatures decrease cellular metabolism and, as a result, interfere with natural replenishment and healing.

The following video demonstrates the simplicity of design and use of the Therapeutic Device:

Prior to initiating a formal clinical trial, Dr Allen reached and monitored online a large number of BPH patients, who were typically in the “watchful waiting” stage of their treatment. This way, Dr Allen obtained a sufficient amount of empirical evidence supporting the effectiveness of Thermobalancing therapy. In 2011, the Director of the Oxford Innovation Centre in the UK interviewed Dr Allen’s patient with BPH. This testimonial was shared online:

Encouraged by initial treatment results and positive user feedback, Dr Allen decided to carry out a formal clinical study. Professor Ivan Aghajanian, Chief Urologist and the founder of the Armenian Association of Urology, hosted and conducted the clinical trial on the efficacy of thermobalancing therapy and the device at the Department of Urology of the Institute of Surgery Mikaelyan, a leading hospital and research centre in Armenia.

Dr Allen’s Device for Prostate Care worked well. Almost all men with BPH had reduction of the prostate size over time. However, it was found that in some cases the lower urinary tract symptoms relief was coming slowly due to the involvement of problems with a bladder, especially when men were on BPH medications for a long period of time. Overall, the results of this study demonstrate improvement in men with BPH after treatment with Therapeutic Device with positive effects in the IPSS symptom score, PV, and uroflowmetry parameters.

Written By: 

 Dr. Simon Allen, MD, PhD. 

Read the Abstract